A federal judge halted the government’s approval of mifepristone on Friday, one of two drugs typically taken in a medication abortion, prompting abortion providers and multiple states to look to ...
With a federal judge's recent ruling clouding the future availability of mifepristone for terminating pregnancies, attention has shifted to the efficacy of another abortion drug, misoprostol. Experts ...
Over the past decade, Louisiana hospitals began stocking specialized carts designed to treat hemorrhages, one of the most ...
Add Yahoo as a preferred source to see more of our stories on Google. Are abortion pills mifepristone and misoprostol still available across the U.S.? Here's what experts say. (Illustration: Nathalie ...
A federal judge in Texas on Friday suspended the Food and Drug Administration’s longtime approval of the drug mifepristone for use in medication abortions, a ruling that is set to go into effect on ...
Louisiana hospitals have locked up a key drug used to stop women from bleeding out after giving birth as a new state law takes effect Tuesday. The law, named Act 246, classifies two common pregnancy ...
Only Slate Plus members can gift Slate stories. Become a member to share 10 free articles a month. When people refer to “the abortion pill,” they’re usually talking about mifepristone, the ...
Ever since the Supreme Court overruled Roe v. Wade in 2022, it's felt like abortion restrictions have been coming at us left and right. And by now, you're probably familiar with alllll of the drama ...
Even if US District Judge Matthew Kacsmaryk’s decision to suspend the US Food and Drug Administration’s approval of mifepristone goes through, there still will be a nonsurgical option for people to ...
As federal courts weigh the future of mifepristone access, some clinicians are preparing for a scenario many hoped was behind them: relying on misoprostol-only regimens for both abortion and early ...
As the Supreme Court weighs the future of mifepristone, a key abortion drug used for terminating early pregnancies, the threat of restricting its use has also put the spotlight on a second medication, ...